Evidence map›Paper›PMID 34262702›Full record

ArticleFood science & nutrition2021

Ameliorative impacts of

Mohamed A Nassan, Mohamed M Soliman, Adil Aldhahrani, Fayez Althobaiti, Adel Q Alkhedaide

Open access · hybridAbstract read
In one paragraph

Article in Food science & nutrition, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Protective Effects of Licorice (Pharmaceuticals (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Ameliorative Effects ofInternational journal of nephrology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Metabolite profiling and nephroprotective potential ofIranian journal of basic medical sciences · 2022
    Article
  11. Nephroprotective Effect ofJournal of toxicology · 2022
    Article
  12. Ameliorative impacts ofFood science & nutrition · 2021
    Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Mohamed A NassanDepartment of Clinical Laboratory Sciences Turabah University College Taif University Taif Saudi Arabia.ORCID https://orcid.org/0000-0002-2806-9136
Mohamed M SolimanDepartment of Clinical Laboratory Sciences Turabah University College Taif University Taif Saudi Arabia.ORCID https://orcid.org/0000-0001-7208-7123
Adil AldhahraniDepartment of Clinical Laboratory Sciences Turabah University College Taif University Taif Saudi Arabia.ORCID https://orcid.org/0000-0003-2387-3042
Fayez AlthobaitiBiotechnology Department College of Science Taif University Taif Saudi Arabia.ORCID https://orcid.org/0000-0002-8344-9238
Adel Q AlkhedaideDepartment of Clinical Laboratory Sciences Turabah University College Taif University Taif Saudi Arabia.ORCID https://orcid.org/0000-0002-5008-8421
Taif University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gentamicin is an effective antibiotic that has been used worldwide for many years. While considered an essential medicine by the WHO, gentamicin can also lead to severe kidney damage. This study explored the ameliorative effects of

Indexed as

BaxCox2gentamicinGlycyrrhiza glabraNrf2

Identifiers

PMID34262702
PMCPMC8269671
OpenAlexW3165463816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.